German Biotech Publishes First-in-Human Data on Rabies mRNA Vaccine
CureVac has published proof-of-concept data for an mRNA rabies vaccine that could open the door…
26/07/2017 - 3 minutes
mRNA: A New Technology Moving into the Mainstream
Messenger RNA (mRNA) technology is based on the idea that human cells can be used as on-demand factories to develop therapeutic proteins by giving them instructions in the form of mRNA. Although mRNA therapeutics and vaccines could be found in drug development pipelines before Covid-19 emerged, the pandemic suddenly moved the mRNA technology into the limelight.
Now, the world has seen mass vaccinations using mRNA-based vaccines developed by Moderna and Pfizer/BioNTech. But the mRNA technology holds promise for other indications as well, including cancer and rare diseases. Read on to learn how this new technology is moving into the mainstream with an influx of investments and new discoveries.
Show More
Editor's Picks for mRNA technology
- Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
- Covid-19 Pandemic Drives RNA Therapeutics into the Mainstream
- EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19
- Next-Generation mRNA Vaccine Technology Unveiled in Series A Round
- Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology
European Biotech Industry Report 2021
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations.
Go to ReportLatest mRNA technology Articles
Results are in from the First Human Trial of an Universal Cancer Vaccine
BioNTech has published results from the first clinical trial for an mRNA-based individualized vaccine with…
05/07/2017 - 4 minutes
Video: Is mRNA a True Game-Changer? Fireside Chat with Sean Marett, COO of BioNTech
Sean Marett took a red-eye from New York to speak at Refresh last month: here…
03/07/2017 - 1 minute
Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma
eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy…
30/06/2017 - 2 minutes
BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies
BioNTech has reported a new technology that could overcome some of the most challenging issues…
12/06/2017 - 3 minutes
Infographic: Who’s who in the mRNA Therapeutics Field in Europe?
The young field of mRNA therapeutics is booming and generating huge expectations. Which are the main players…
26/04/2017 - 1 minute
Shire sells its RNA platform to a US-based Biotech
Shire has sold its RNA therapy program to a smaller biotech that wants to accelerate…
05/01/2017 - 2 minutes
10 Hot European Biotechs to Observe in 2017 🚀
New year, new list: here are the 10 hottest Biotech companies I will watch closely…
03/01/2017 - 5 minutes
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…
26/12/2016 - 5 minutes
These are our 10 Most Read Biotech Articles of 2016
From the hottest research areas to the most popular city for biotech, which biotech articles have…
20/12/2016 - 4 minutes
Up, up and away! CureVac’s money pile now Totals €325M
CureVac has raised an additional €27M ($29.5M) that will help the company keep on its…
09/11/2016 - 3 minutes
German Biotech allies with Genentech in battle for Cancer Vaccine
BioNTech has turned up the heat in the race to bring an mRNA immunotherapy for…
21/09/2016 - 3 minutes
